Carol G. Gallagher, PharmD has over thirty-five years of experience in the Biopharmaceutical industry in both business and drug-development roles, as a CEO, and as a venture capital investor. She has been involved in the development of five approved therapies. She has also served as an advisor to large pharma and academic institutions. Currently, she serves as chairman or as a director on several biopharma boards. In addition to The Leukemia & Lymphoma Society, her philanthropic interests include serving on the board of trustees at the Salk Institute and as a board member of Life Science Cares San Diego. She previously served on the board of Sharp Healthcare which is an integrated healthcare provider in San Diego. Dr. Gallagher attended Vanderbilt University and received BS and Doctor of Pharmacy degrees from the University of Kentucky College of Pharmacy.
